Exosomes from activated NK cells (primary or NK92), stimulated with IL-2, IL-12, and IL-15, display increased penetrability, solid tumor targeting capacity, and enhanced cytotoxicity against tumor cells, attributed to granzyme B and H enrichment [241,242]. The gene discussed is IL2; the disease is neoplasm.